130 related articles for article (PubMed ID: 34730871)
1. Role of Hepatocyte-Derived Osteopontin in Liver Carcinogenesis.
Desert R; Ge X; Song Z; Han H; Lantvit D; Chen W; Das S; Athavale D; Abraham-Enachescu I; Blajszczak C; Chen Y; Musso O; Guzman G; Hoshida Y; Nieto N
Hepatol Commun; 2022 Apr; 6(4):692-709. PubMed ID: 34730871
[TBL] [Abstract][Full Text] [Related]
2. Signalling via the osteopontin and high mobility group box-1 axis drives the fibrogenic response to liver injury.
Arriazu E; Ge X; Leung TM; Magdaleno F; Lopategi A; Lu Y; Kitamura N; Urtasun R; Theise N; Antoine DJ; Nieto N
Gut; 2017 Jun; 66(6):1123-1137. PubMed ID: 26818617
[TBL] [Abstract][Full Text] [Related]
3. Micro-RNA-181a regulates osteopontin-dependent metastatic function in hepatocellular cancer cell lines.
Bhattacharya SD; Garrison J; Guo H; Mi Z; Markovic J; Kim VM; Kuo PC
Surgery; 2010 Aug; 148(2):291-7. PubMed ID: 20576283
[TBL] [Abstract][Full Text] [Related]
4. C-C chemokine receptor type 1 mediates osteopontin-promoted metastasis in hepatocellular carcinoma.
Zhu Y; Gao XM; Yang J; Xu D; Zhang Y; Lu M; Zhang Z; Sheng YY; Li JH; Yu XX; Zheng Y; Dong QZ; Qin LX
Cancer Sci; 2018 Mar; 109(3):710-723. PubMed ID: 29285854
[TBL] [Abstract][Full Text] [Related]
5. Osteopontin increases hepatocellular carcinoma cell growth in a CD44 dependant manner.
Phillips RJ; Helbig KJ; Van der Hoek KH; Seth D; Beard MR
World J Gastroenterol; 2012 Jul; 18(26):3389-99. PubMed ID: 22807608
[TBL] [Abstract][Full Text] [Related]
6. Suppression of osteopontin inhibits chemically induced hepatic carcinogenesis by induction of apoptosis in mice.
Lee SH; Park JW; Woo SH; Go DM; Kwon HJ; Jang JJ; Kim DY
Oncotarget; 2016 Dec; 7(52):87219-87231. PubMed ID: 27888617
[TBL] [Abstract][Full Text] [Related]
7. Role of osteopontin and CD44s expression for patients with hepatocellular carcinoma undergoing liver transplantation or resection.
Beckebaum S; Chen X; Sotiropoulos GC; Radtke A; Daoudaki M; Baba HA; Wohlschlaeger J; Broelsch CE; Gerken G; Cicinnati VR
Transplant Proc; 2008 Nov; 40(9):3182-4. PubMed ID: 19010227
[TBL] [Abstract][Full Text] [Related]
8. Liver haploinsufficiency of RuvBL1 causes hepatic insulin resistance and enhances hepatocellular carcinoma progression.
Mello T; Materozzi M; Zanieri F; Simeone I; Ceni E; Bereshchenko O; Polvani S; Tarocchi M; Marroncini G; Nerlov C; Guasti D; Bani D; Pinzani M; Galli A
Int J Cancer; 2020 Jun; 146(12):3410-3422. PubMed ID: 31721195
[TBL] [Abstract][Full Text] [Related]
9. Intracellular Osteopontin inhibits toll-like receptor signaling and impedes liver carcinogenesis.
Fan X; He C; Jing W; Zhou X; Chen R; Cao L; Zhu M; Jia R; Wang H; Guo Y; Zhao J
Cancer Res; 2015 Jan; 75(1):86-97. PubMed ID: 25398438
[TBL] [Abstract][Full Text] [Related]
10. The osteopontin-CD44 axis in hepatic cancer stem cells regulates IFN signaling and HCV replication.
Shirasaki T; Honda M; Yamashita T; Nio K; Shimakami T; Shimizu R; Nakasyo S; Murai K; Shirasaki N; Okada H; Sakai Y; Sato T; Suzuki T; Yoshioka K; Kaneko S
Sci Rep; 2018 Sep; 8(1):13143. PubMed ID: 30177680
[TBL] [Abstract][Full Text] [Related]
11. IL-17 signaling in steatotic hepatocytes and macrophages promotes hepatocellular carcinoma in alcohol-related liver disease.
Ma HY; Yamamoto G; Xu J; Liu X; Karin D; Kim JY; Alexandrov LB; Koyama Y; Nishio T; Benner C; Heinz S; Rosenthal SB; Liang S; Sun M; Karin G; Zhao P; Brodt P; Mckillop IH; Quehenberger O; Dennis E; Saltiel A; Tsukamoto H; Gao B; Karin M; Brenner DA; Kisseleva T
J Hepatol; 2020 May; 72(5):946-959. PubMed ID: 31899206
[TBL] [Abstract][Full Text] [Related]
12. SHP-1 Acts as a Tumor Suppressor in Hepatocarcinogenesis and HCC Progression.
Wen LZ; Ding K; Wang ZR; Ding CH; Lei SJ; Liu JP; Yin C; Hu PF; Ding J; Chen WS; Zhang X; Xie WF
Cancer Res; 2018 Aug; 78(16):4680-4691. PubMed ID: 29776962
[TBL] [Abstract][Full Text] [Related]
13. CXCR6 Inhibits Hepatocarcinogenesis by Promoting Natural Killer T- and CD4
Mossanen JC; Kohlhepp M; Wehr A; Krenkel O; Liepelt A; Roeth AA; Möckel D; Heymann F; Lammers T; Gassler N; Hermann J; Jankowski J; Neumann UP; Luedde T; Trautwein C; Tacke F
Gastroenterology; 2019 May; 156(6):1877-1889.e4. PubMed ID: 30710528
[TBL] [Abstract][Full Text] [Related]
14. Correlation and prognostic value of osteopontin and Bcl-2 in hepatocellular carcinoma patients after curative resection.
Deng B; Zhang XF; Zhu XC; Huang H; Jia HL; Ye QH; Dong QZ; Qin LX
Oncol Rep; 2013 Dec; 30(6):2795-803. PubMed ID: 24065086
[TBL] [Abstract][Full Text] [Related]
15. Osteopontin, an oxidant stress sensitive cytokine, up-regulates collagen-I via integrin α(V)β(3) engagement and PI3K/pAkt/NFκB signaling.
Urtasun R; Lopategi A; George J; Leung TM; Lu Y; Wang X; Ge X; Fiel MI; Nieto N
Hepatology; 2012 Feb; 55(2):594-608. PubMed ID: 21953216
[TBL] [Abstract][Full Text] [Related]
16. Osteopontin binding to lipopolysaccharide lowers tumor necrosis factor-α and prevents early alcohol-induced liver injury in mice.
Ge X; Leung TM; Arriazu E; Lu Y; Urtasun R; Christensen B; Fiel MI; Mochida S; Sørensen ES; Nieto N
Hepatology; 2014 Apr; 59(4):1600-16. PubMed ID: 24214181
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic and Prognostic Roles of Serum Osteopontin and Osteopontin Promoter Polymorphisms in Hepatitis B-related Hepatocellular Carcinoma.
Chimparlee N; Chuaypen N; Khlaiphuengsin A; Pinjaroen N; Payungporn S; Poovorawan Y; Tangkijvanich P
Asian Pac J Cancer Prev; 2015; 16(16):7211-7. PubMed ID: 26514514
[TBL] [Abstract][Full Text] [Related]
18. Context-specific roles of diphthamide deficiency in hepatocellular carcinogenesis.
Tu WL; Chih YC; Shih YT; Yu YR; You LR; Chen CM
J Pathol; 2022 Oct; 258(2):149-163. PubMed ID: 35781884
[TBL] [Abstract][Full Text] [Related]
19. Role of hepatitis C virus induced osteopontin in epithelial to mesenchymal transition, migration and invasion of hepatocytes.
Iqbal J; McRae S; Mai T; Banaudha K; Sarkar-Dutta M; Waris G
PLoS One; 2014; 9(1):e87464. PubMed ID: 24498111
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of androgen/AR signaling inhibits diethylnitrosamine (DEN) induced tumour initiation and remodels liver immune cell networks.
Helms TH; Mullins RD; Thomas-Ahner JM; Kulp SK; Campbell MJ; Lucas F; Schmidt N; LeMoine DM; Getaneh S; Xie Z; Phelps MA; Clinton SK; Coss CC
Sci Rep; 2021 Feb; 11(1):3646. PubMed ID: 33574348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
